Literature DB >> 21523452

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Margaret M Madeleine1, Lisa G Johnson, Mari Malkki, Alexa J Resler, Effie W Petersdorf, Barbara McKnight, Kathleen E Malone.   

Abstract

Proinflammatory cytokines are associated with age-related diseases including arthritis and heart disease. IL6 and TNF also play key roles in estrogen modulation in older women. We explored whether variation in IL6 and TNF genes influenced the risk of breast cancer in samples that differed by age group: <44 years (228 cases and 271 controls), 45-64 years (426 cases and 396 controls), and 65+ years (228 cases and 239 controls). Samples were drawn from population-based case-control studies conducted in Seattle. Age-adjusted odds ratios (ORs) were calculated to evaluate the risk associated with variants in IL6, IL6R, TNF, and TNFRSF1A. There was a significantly increased risk of breast cancer associated with one or more C>T alleles at IL6 rs2069861 among subjects in the oldest age group (OR 1.8, 95% CI 1.1-2.9), but no overall increased risk of breast cancer associated with any IL6 or IL6R variants in the combined data. There were significantly elevated risks of breast cancer among women 45-64 years old associated with a UTR 5' flanking SNP LTA rs2009658 C>G allele (OR 1.5, 95% CI 1.1-1.9) and a nonsynonomous coding SNP TNFRSF1A rs767455 T>C allele (OR 1.3, 95% CI 1.1-1.6); these two variants were also elevated in the combined data (OR 1.3, 95% CI 1.1-1.5 and OR 1.2, 95% CI 1.1-1.4, respectively). This study supports a modest association between a variant in IL6 and breast cancer among older women and TNF-related variants and breast cancer among middle-aged women. Further evaluation of these genes in other studies is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523452      PMCID: PMC3164911          DOI: 10.1007/s10549-011-1520-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

Review 1.  The surveillance, epidemiology, and end results program: a national resource.

Authors:  B F Hankey; L A Ries; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

Review 2.  Changes in proinflammatory cytokine activity after menopause.

Authors:  Johannes Pfeilschifter; Roland Köditz; Martin Pfohl; Helmut Schatz
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

3.  The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results.

Authors:  Polly A Marchbanks; Jill A Mcdonald; Hoyt G Wilson; Nancy M Burnett; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Brian L Strom; Sandra A Norman; Linda K Weiss; Jonathan M Liff; Phyllis A Wingo; Ronald T Burkman; Suzanne G Folger; Jesse A Berlin; Dennis M Deapen; Giske Ursin; Ralph J Coates; Michael S Simon; Michael F Press; Robert Spirtas
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

4.  Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis.

Authors:  Chao Shen; Haiming Sun; Donglin Sun; Lidan Xu; Xuelong Zhang; An Liu; Xueyuan Jia; Jing Bai; Feng Chen; Yang Yu; Yan Jin; Jingcui Yu; Songbin Fu
Journal:  Breast Cancer Res Treat       Date:  2010-09-30       Impact factor: 4.872

5.  Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

Authors:  Nicola M Suter; Kathleen E Malone; Janet R Daling; David R Doody; Elaine A Ostrander
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

6.  The HLA class III subregion is responsible for an increased breast cancer risk.

Authors:  Mirjam M de Jong; Ilja M Nolte; Elisabeth G E de Vries; Michael Schaapveld; Jan H Kleibeuker; Elvira Oosterom; Jan C Oosterwijk; Annemarie H van der Hout; Gerrit van der Steege; Marcel Bruinenberg; H Marike Boezen; Gerard J Te Meerman; Winette T A van der Graaf
Journal:  Hum Mol Genet       Date:  2003-07-22       Impact factor: 6.150

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.

Authors:  Christopher I Li; Kathleen E Malone; Peggy L Porter; Noel S Weiss; Mei-Tzu C Tang; Janet R Daling
Journal:  Int J Cancer       Date:  2003-11-20       Impact factor: 7.396

Review 9.  Inflammatory cells and cancer: think different!

Authors:  L M Coussens; Z Werb
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

Review 10.  The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.

Authors:  Atul Purohit; Simon P Newman; Michael J Reed
Journal:  Breast Cancer Res       Date:  2002-01-14       Impact factor: 6.466

View more
  16 in total

1.  Cardiac autonomic evaluation in breast cancer patients: role of cytokines and heart rate recovery.

Authors:  Sercan Okutucu; Mehmet Kadri Akboga; Cengiz Sabanoglu; Ali Oto
Journal:  Clin Res Cardiol       Date:  2018-06-12       Impact factor: 5.460

2.  Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Jennifer S Herrick; Gabriella Torres-Mejia; Esther M John; Anna R Giuliano; Lisa M Hines; Mariana C Stern; Kathy B Baumgartner; Angela P Presson; Roger K Wolff
Journal:  Carcinogenesis       Date:  2014-03-26       Impact factor: 4.944

3.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

4.  Association between the tumor necrosis factor alpha gene -308G> A polymorphism and the risk of breast cancer: a meta-analysis.

Authors:  Guojiang Jin; Yan Zhao; Shuang Sun; Hui Kang
Journal:  Tumour Biol       Date:  2014-08-24

5.  Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans.

Authors:  Hai Lian; Lei Wang; Jingmin Zhang
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

6.  Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer.

Authors:  Hui-Hui Li; Hui Zhu; Li-Sheng Liu; Yong Huang; Jun Guo; Jie Li; Xin-Ping Sun; Chun-Xiao Chang; Zhe-Hai Wang; Kan Zhai
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

7.  Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).

Authors:  Zhihong Gong; Lei Quan; Song Yao; Gary Zirpoli; Elisa V Bandera; Michelle Roberts; Jean-Gabriel Coignet; Citadel Cabasag; Lara Sucheston; Helena Hwang; Gregory Ciupak; Warren Davis; Karen Pawlish; Lina Jandorf; Dana H Bovbjerg; Christine B Ambrosone; Chi-Chen Hong
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

Review 8.  Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.

Authors:  Yi Huang; Xi Yu; Lingyan Wang; Shengjun Zhou; Jie Sun; Nan Feng; Sheng Nie; Jingmi Wu; Feng Gao; Bing Fei; Jianyong Wang; Zhiqing Lin; Xianru Li; Leiting Xu; Xiang Gao; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

Review 9.  Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research.

Authors:  Yin Ting Cheung; Si Rong Lim; Han Kiat Ho; Alexandre Chan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Authors:  Alexa J Resler; Kathleen E Malone; Lisa G Johnson; Mari Malkki; Effie W Petersdorf; Barbara McKnight; Margaret M Madeleine
Journal:  BMC Cancer       Date:  2013-05-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.